SCHEMBL7449098

SCHEMBL7449098

CCOC(=O)c1nc(C(C)(C)O)cnc1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 8/20 0.43
HTT P42858 2/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
RECQL P46063 1/20 0.43
NPC1 O15118 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
MAPT P10636 3/20 0.42
RAB9A P51151 3/20 0.42
TP53 P04637 2/20 0.42
HSP90AA1 P07900 1/20 0.42
XBP1 P17861 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TLR9 Q9NR96 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29722018 0.85 KDM4E (0.53) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL24550855 0.85 KDM4E (0.53) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL1761085 0.80 ALDH1A1 (0.49) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL5621275 0.78 ALDH1A1 (0.47) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL7451722 0.77 SYK (0.38) KDM4EALDH1A1HTTCYP1A2NPC1
SCHEMBL7454636 0.76 PDE10A (0.52)
SCHEMBL2371415 0.75 KDM4E (0.52) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL30206120 0.75 KDM4E (0.52) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL2843820 0.73 ALDH1A1 (0.59) KDM4EALDH1A1HTTHPGDCYP1A2
SCHEMBL29642902 0.73 RAB9A (0.55) KDM4EALDH1A1CYP1A2NPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A KDM4E 2322/4885ALDH1A1 271/4885HTT 2110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.